synapsin i antibody Search Results


95
Proteintech syn1
Syn1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/SYN1-Specific+Antibody/pm41616945-105-54-56
Average 95 stars, based on 1 article reviews
syn1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
PhosphoSolutions phospho s9 synapsin i
Phospho S9 Synapsin I, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Anti-Synapsin+I+(Ser9)+Antibody/pmc06605539-70-3-9
Average 96 stars, based on 1 article reviews
phospho s9 synapsin i - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PhosphoSolutions synapsin i
In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 <t>synapsin</t> <t>I</t> after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.
Synapsin I, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Anti-Synapsin+I+Antibody/pmc09134315-143-13-15
Average 96 stars, based on 1 article reviews
synapsin i - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Boster Bio anti syn1
In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 <t>synapsin</t> <t>I</t> after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.
Anti Syn1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Anti-Synapsin+I%2FSYN1+Antibody+Picoband/pm41566018-150-48-50
Average 90 stars, based on 1 article reviews
anti syn1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Novus Biologicals synapsin 1
In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 <t>synapsin</t> <t>I</t> after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.
Synapsin 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Synapsin+I+%5Bp+Ser9%5D+Antibody+(SR2212)/pmc01973147-250-27-28
Average 90 stars, based on 1 article reviews
synapsin 1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Novus Biologicals anti synapsin
In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 <t>synapsin</t> <t>I</t> after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.
Anti Synapsin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Synapsin+I+Antibody/pmc03972420-114-28-31
Average 93 stars, based on 1 article reviews
anti synapsin - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Novus Biologicals synapsin
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Synapsin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Synapsin+I+Antibody/pm37175535-395-18-21
Average 93 stars, based on 1 article reviews
synapsin - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Novus Biologicals nb300-104
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Nb300 104, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Synapsin+I+Antibody/pmc03686744-64-9--1
Average 94 stars, based on 1 article reviews
nb300-104 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
PhosphoSolutions anti phosphosynapsin 1 ser 603
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Anti Phosphosynapsin 1 Ser 603, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Anti-Synapsin+I+(Ser603)+Antibody/10__1074_slash_jbc__m112__369058-58-39-42
Average 96 stars, based on 1 article reviews
anti phosphosynapsin 1 ser 603 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PhosphoSolutions synapsin
NMDA receptors greatly influence the electrophysiological signature of NP spheroids embedded in the nanocomposite. A) Representative IF images showing the 14‐day expression of <t>synapsin</t> <t>and</t> <t>β</t> III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were counterstained with DAPI. Scale bar: 100 µm. B) Representative IF images of NMDAr and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were stained with DAPI. Scale bar: 100 µm. C) Western blot analysis of synapsin and NMDAr expressions. D) Quantification of synapsin expression levels. E) Quantification of NMDAr expression levels. F) Percentage firing rate deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. G) Network burst frequency deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. All numerical data are presented as mean ± SD. Statistical significance was determined using one‐way ANOVA and Tukey's HSD post hoc test: ** p < 0.01, * p < 0.05, ns p > 0.05.
Synapsin, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Anti-Synapsin+I+Antibody/pmc11481026-10-10-11
Average 96 stars, based on 1 article reviews
synapsin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Rockland Immunochemicals anti synapsin phospho ser 603 rabbit polyclonal
NMDA receptors greatly influence the electrophysiological signature of NP spheroids embedded in the nanocomposite. A) Representative IF images showing the 14‐day expression of <t>synapsin</t> <t>and</t> <t>β</t> III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were counterstained with DAPI. Scale bar: 100 µm. B) Representative IF images of NMDAr and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were stained with DAPI. Scale bar: 100 µm. C) Western blot analysis of synapsin and NMDAr expressions. D) Quantification of synapsin expression levels. E) Quantification of NMDAr expression levels. F) Percentage firing rate deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. G) Network burst frequency deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. All numerical data are presented as mean ± SD. Statistical significance was determined using one‐way ANOVA and Tukey's HSD post hoc test: ** p < 0.01, * p < 0.05, ns p > 0.05.
Anti Synapsin Phospho Ser 603 Rabbit Polyclonal, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/SYNAPSIN+I+PHOSPHO+S603+ANTIBODY/pmc06415872-558-16-21
Average 90 stars, based on 1 article reviews
anti synapsin phospho ser 603 rabbit polyclonal - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Novus Biologicals p synapsin i
NMDA receptors greatly influence the electrophysiological signature of NP spheroids embedded in the nanocomposite. A) Representative IF images showing the 14‐day expression of <t>synapsin</t> <t>and</t> <t>β</t> III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were counterstained with DAPI. Scale bar: 100 µm. B) Representative IF images of NMDAr and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were stained with DAPI. Scale bar: 100 µm. C) Western blot analysis of synapsin and NMDAr expressions. D) Quantification of synapsin expression levels. E) Quantification of NMDAr expression levels. F) Percentage firing rate deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. G) Network burst frequency deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. All numerical data are presented as mean ± SD. Statistical significance was determined using one‐way ANOVA and Tukey's HSD post hoc test: ** p < 0.01, * p < 0.05, ns p > 0.05.
P Synapsin I, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i+antibody/Synapsin+I+%5Bp+Ser62%2C+p+Ser67%5D+Antibody/pmc10332249-153-67-71
Average 94 stars, based on 1 article reviews
p synapsin i - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 synapsin I after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.

Journal: Frontiers in Pharmacology

Article Title: Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior

doi: 10.3389/fphar.2022.863762

Figure Lengend Snippet: In vivo efficacy and in vitro specificity of 25–106 (A) . Quantitative immunoblot analysis of striatal brain lysates for phospho-Ser549 synapsin I after dosing 50 mg/kg 25–106 across the times indicated ( n = 4 per group) (B) . Quantitative immunoblot of phospho-Ser549 synapsin I 24 h post administration across doses indicated ( n = 4 per group). (C) . In vitro kinase assay (30 min) with Cdk2/Cyclin E, Cdk5/p25, and Cdk9/Cyclin T1 treated with 0–5 µM 25–106 (left) calculated IC 50, K i values of each kinase (right). * p <0.05 student’s t -test.

Article Snippet: The following antibodies were used in the study: phospho-Ser549 synapsin I (Phosphosolutions), total synapsin I (Phosphosolutions), actin (Invitrogen), phospho-Ser1116 (in-house) , and total NR2B (Phosphosolutions), phospho-Thr75, and total DARPP-32 (Cell Signaling Technology).

Techniques: In Vivo, In Vitro, Western Blot, Kinase Assay

Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels of PSD95, synapsin, synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.

Journal: International journal of molecular sciences

Article Title: Treadmill Exercise Alleviates Cognition Disorder by Activating the FNDC5: Dual Role of Integrin αV/β5 in Parkinson's Disease.

doi: 10.3390/ijms24097830

Figure Lengend Snippet: Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels of PSD95, synapsin, synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.

Article Snippet: These primary antibodies included TH (1:1000, ab112, Abcam, Shanghai, China), PSD95 (1:1000, 3450S, CST, Fall River, MA, USA), Synapsin (1:1000, NB300-104, NOVUS (Shanghai) Co. Ltd, Centennial, CO, USA), CAMKII(1:1000, 50049S, CST, Fall River, MA, USA), SNAP47 (1:1000, ab172609, Abcam, Shanghai, China), Synaptophysin (1:1000, ab52636, Abcam, Shanghai, China), BDNF (1:200, ANT-010, Alomone Labs, Jerusalem, Israel), FNDC5 (1:1000, bs-8486R, Bioss, Beijing, China), integrin αV (1:200, sc-9969, Santa Cruz, Dallas, TX, USA), integrin β5 (1:200, sc398214, Santa Cruz, Dallas, TX, USA), and β-actin (1:5000, 60008-1-Ig, Proteintech, Wuhan, China).

Techniques: Western Blot, Staining, Control

NMDA receptors greatly influence the electrophysiological signature of NP spheroids embedded in the nanocomposite. A) Representative IF images showing the 14‐day expression of synapsin and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were counterstained with DAPI. Scale bar: 100 µm. B) Representative IF images of NMDAr and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were stained with DAPI. Scale bar: 100 µm. C) Western blot analysis of synapsin and NMDAr expressions. D) Quantification of synapsin expression levels. E) Quantification of NMDAr expression levels. F) Percentage firing rate deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. G) Network burst frequency deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. All numerical data are presented as mean ± SD. Statistical significance was determined using one‐way ANOVA and Tukey's HSD post hoc test: ** p < 0.01, * p < 0.05, ns p > 0.05.

Journal: Advanced Healthcare Materials

Article Title: Electroconductive Collagen‐Carbon Nanodots Nanocomposite Elicits Neurite Outgrowth, Supports Neurogenic Differentiation and Accelerates Electrophysiological Maturation of Neural Progenitor Spheroids

doi: 10.1002/adhm.202301894

Figure Lengend Snippet: NMDA receptors greatly influence the electrophysiological signature of NP spheroids embedded in the nanocomposite. A) Representative IF images showing the 14‐day expression of synapsin and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were counterstained with DAPI. Scale bar: 100 µm. B) Representative IF images of NMDAr and β III‐tubulin in spheroids cultured in CE, CE_rCND1, and CE_CND1 matrices. Nuclei were stained with DAPI. Scale bar: 100 µm. C) Western blot analysis of synapsin and NMDAr expressions. D) Quantification of synapsin expression levels. E) Quantification of NMDAr expression levels. F) Percentage firing rate deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. G) Network burst frequency deviations from baseline recordings following acute MK‐801 and NBQX treatment performed at 14 and 28 DIV. All numerical data are presented as mean ± SD. Statistical significance was determined using one‐way ANOVA and Tukey's HSD post hoc test: ** p < 0.01, * p < 0.05, ns p > 0.05.

Article Snippet: β‐III tubulin (Abcam, ab78078) MAP2 (ThermoFisher, PA5‐17646) Ki‐67 (ThermoFisher, 14–569) Synapsin (Phosphosolution, 1927‐SYNP) NMDAR2D extracellular (ThermoFisher, PA577425) Nestin (Abcam, ab105389) Calretinin (Abcam, ab92341) , 1:1000 1:500 1:250 1:500 1:200 1:500 1:500 , Anti‐goat Alexa 488 Anti‐rat Alexa 555 Anti‐mouse Alexa 594 Anti‐rabbit Alexa 647 , 1:500 1:500 1:500 1:500.

Techniques: Expressing, Cell Culture, Staining, Western Blot

List of primary and secondary antibodies, with their working dilution, used in this study.

Journal: Advanced Healthcare Materials

Article Title: Electroconductive Collagen‐Carbon Nanodots Nanocomposite Elicits Neurite Outgrowth, Supports Neurogenic Differentiation and Accelerates Electrophysiological Maturation of Neural Progenitor Spheroids

doi: 10.1002/adhm.202301894

Figure Lengend Snippet: List of primary and secondary antibodies, with their working dilution, used in this study.

Article Snippet: β‐III tubulin (Abcam, ab78078) MAP2 (ThermoFisher, PA5‐17646) Ki‐67 (ThermoFisher, 14–569) Synapsin (Phosphosolution, 1927‐SYNP) NMDAR2D extracellular (ThermoFisher, PA577425) Nestin (Abcam, ab105389) Calretinin (Abcam, ab92341) , 1:1000 1:500 1:250 1:500 1:200 1:500 1:500 , Anti‐goat Alexa 488 Anti‐rat Alexa 555 Anti‐mouse Alexa 594 Anti‐rabbit Alexa 647 , 1:500 1:500 1:500 1:500.

Techniques: